Top

International Journal of Colorectal Disease

Published in:

01-03-2017 | Review

Mucosa-associated lymphoid tissue (MALT) variant of primary rectal lymphoma: a review of the English literature

Author: Scott R. Kelley

Published in: International Journal of Colorectal Disease | Issue 3/2017

Abstract

Purpose

Primary rectal lymphoma (PRL) is the third most common cause of rectal cancer following adenocarcinoma (90–95 %) and carcinoid (5 %). The most common variant of PRL is the mucosa-associated lymphoid tissue (MALT) type. To date, no study has been able to recommend an optimal treatment algorithm for this rare disease. The aim of our study was to review the English literature on primary rectal MALT lymphoma.

Methods

A review of the English literature was conducted to identify articles describing the MALT variant of PRL.

Results

Fifty-one cases were identified. A complete response was achieved in 12 of 19 cases treated with Helicobacter pylori eradication therapy, 5 of 6 with radiation, 2 of 4 cases with chemotherapy, 2 of 4 with endoscopic resection, 6 of 8 cases with surgical resection, and all 8 with combination therapies. Cases failing initial therapies were responsive to various second-line treatments. Two cases spontaneously regressed with observation alone.

Conclusion

Complete regression of primary rectal MALT lymphoma was achieved using various therapeutic strategies, although the numbers of different treatment modalities are too small to draw definitive conclusions.

Dawson IM, Cornes JS, Morson BC (1961) Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 49:80–89CrossRefPubMed

Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (2000) The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol 13:193–207CrossRefPubMed

Bschorer R, Lingenfelser T, Kaiserling E, Schwenzer N (1993) Malignant lymphoma of the mucosa-associated lymphoid tissue (MALT)—consecutive unusual manifestation in the rectum and gingiva. J Oral Pathol Med 22(4):190–192CrossRefPubMed

Matsumoto T, Shimizu M, Iida M, Amano K, Nakamura S, Fujishima M (1998) Primary low-grade, B-cell, mucosa-associated lymphoid tissue lymphoma of the colorectum: clinical and colonoscopic features in six cases. Gastrointest Endosc 48(5):501–508CrossRefPubMed

Yatabe Y, Nakamura S, Nakamura T, Seto M, Ogura M, Kimura M, Kuhara H, Kobayashi T, Taniwaki M, Morishima Y, Koshikawa T, Suchi T (1998) Multiple polypoid lesions of primary mucosa-associated lymphoid-tissue lymphoma of colon. Histopathology 32(2):116–125CrossRefPubMed

Inoue F, Chiba T (1999) Regression of MALT lymphoma of the rectum after anti-H. pylori therapy in a patient negative for H. pylori. Gastroenterology 117(2):514–515CrossRefPubMed

Orita M, Yamashita K, Okino M, Enoki T, Noshima S, Morita N, Esato K (1999) A case of MALT (mucosa-associated lymphoid tissue) lymphoma occurring in the rectum. Hepato-Gastroenterology 46(28):2352–2354PubMed

Okamura S, Katsuhiko H, Satoh T (2000) Regression of rectal mucosa-associated lymphoid tissue lymphoma unrelated to Helicobacter pylori. Ann Intern Med 132(3):247CrossRefPubMed

Takenaka R, Tomoda J, Sakata T, Ichiba T, Motoi M, Mizuno M, Tsuji T (2000) Mucosa-associated lymphoid tissue lymphoma of the rectum that regressed spontaneously. J Gastroenterol Hepatol 15(3):331–335CrossRefPubMed

10.

Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, Crump M (2001) Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radial Oncol Eiol Phys 50:1258–1264CrossRef

11.

Hisabe T, Imamura K, Furukawa K, Tsuda S, Matsui T, Yao T, Kanda M, Ohshima K, Kikuchi M (2002) Regression of CD5-positive and Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the rectum after administration of antibiotics: report of a case. Dis Colon rectum 45(9):1267–1270

12.

Nakase H, Okazaki K, Ohana M, Ikeda K, Uchida K, Uose S, Itoh T, Iwano M, Watanabe N, Yazumi S, Kawanami C, Inoue F, Chiba T (2002) The possible involvement of micro-organisms other than Helicobacter pylori in the development of rectal MALT lymphoma in H. pylori-negative patients. Endoscopy 34(4):343–346CrossRefPubMed

13.

Tanimoto A, Hamada T, Yamamoto T, Kimura S, Matsuki Y, Sasaguri Y (2002) MALT lymphoma with extreme plasma cell differentiation of the rectum. Am J Gastroenterol 97(7):1860–1862CrossRefPubMed

14.

Navarra G, Adani GL, Bardella E, Ascanelli S, Turini A, Pozza E (2003) Primary rectal lymphoma as a cause of bowel obstruction. Report of a case Tumori 89(1):88–90PubMed

15.

Dohden K, Kaizaki Y, Hosokawa O, Hayashi H, Hattori M (2004) Regression of rectal mucosa-associated lymphoid tissue lymphoma but persistence of Helicobacter pylori infection of gastric mucosa after administration of levofloxacin: report of a case. Dis Colon rectum 47(9):1544–1546CrossRefPubMed

16.

Ahlawat S, Haddad N, Kanber Y, Cohen P, Ozdemirli M, Benjamin S (2005) Primary mucosa-associated lymphoid tissue lymphoma occurring in the rectum. Gastrointest Endosc 62(3):443–444CrossRefPubMed

17.

Kikuchi Y, Matsui T, Hisabe T, Wada Y, Hoashi T, Tsuda S, Yao T, Iwashita A, Imamura K (2005) Deep infiltrative low-grade MALT (mucosal-associated lymphoid tissue) colonic lymphomas that regressed as a result of antibiotic administration: endoscopic ultrasound evaluation. J Gastroenterol 40(8):843–847CrossRefPubMed

18.

Yamamoto R, Kato S, Shimazaki K, Yoshizumi T, Uefuji K, Seo M, Matsuura T, Kikuchi M, Itoh K, Miura S 2005 A case of primary rectal mucosa-associated lymphoid tissue lymphoma treated by endoscopic mucosal resection. Digestive Endoscopy 17(2):172–174 (http://opensample.info/a-case-of-primary-rectal-mucosa-associated-lymphoid-tissue-lymphoma-treated-by-endoscopic-mucosal-resection)

19.

Foo M, Chao MW, Gibbs P, Guiney M, Jacobs R (2008) Successful treatment of mucosa-associated lymphoid tissue lymphoma of the rectum with radiation therapy: report of a case. Dis Colon rectum 51(11):1719–1723CrossRefPubMed

20.

Hwang WS, Ye H, Lin S, Chuang S 2008 Primary rectal mucosa-associated lymphoid tissue lymphoma: report of a case with extensive FISH study. Open Pathology Journal 2:28–30 (http://benthamopen.com/ABSTRACT/TOPATJ-2-28)

21.

Kobayashi T, Takahashi N, Hagiwara Y, Tamaru J, Kayano H, Jin-nai I, Bessho M, Niitsu N (2008) Successful radiotherapy in a patient with primary rectal mucosa-associated lymphoid tissue lymphoma without the API2-MALT1 fusion gene: a case report and review of the literature. Leuk Res 32(1):173–175CrossRefPubMed

22.

Amouri A, Chtourou L, Mnif L, Mdhaffar M, Abid M, Ayedi L, Daoud J, Elloumi M, Boudawara T, Tahri N (2009) MALT lymphoma of the rectum: a case report treated by radiotherapy. Cancer Radiother 13(1):61–64CrossRefPubMed

23.

Mathew A, Humburg BC, Bayer MG (2009) A case of rectal MALT lymphoma treated by endoscopic resection. Am J Gastroenterol 104(1):255–256CrossRefPubMed

24.

Chihara D, Kagami Y, Oki Y, Kato H, Onoda H, Ine S, Taji H, Yamamoto K, Morishima Y (2010) R-CHOP therapy for MALT lymphoma of the rectum. Eur J Haematol 84(1):84–86CrossRefPubMed

25.

Ersoz F, Toros AB, Bektas H, Ozcan O, Koc O, Arikan S (2010) MALT lymphoma of the rectum, presenting with rectal prolapsus: a case report. Cases J 3(1):33CrossRefPubMedPubMedCentral

26.

Niino D, Yamamoto K, Tsuruta O, Maeda T, Yakushijin Y, Aoki R, Kimura Y, Hashikawa K, Kiyasu J, Takeuchi M, Sugita Y, Ohshima K (2010) Regression of rectal mucosa-associated lymphoid tissue (MALT) lymphoma after antibiotic treatments. Pathol Int 60(6):438–442CrossRefPubMed

27.

Samee A, Rukin N, Siddiqui I, Halliday M, Farmer M (2010) A solitary rectal mucosa-associated lymphoid tissue (MALT) lymphoma. BMJ Case Rep. 2010:2649

28.

Chahil N, Bloom P, Tyson J, Jazwari S, Robilotti J, Gaultieri N (2011) Novel approach to treatment of rectal mucosa-associated lymphoid tissue lymphoma. BMJ Case Rep 2011:2969PubMed

29.

Yamamoto T, Shinji A, Mukawa K, Ohta H, Komatsu K, Komatsu M, Yamamura N, Nakamura T (2011) A case of rectal mucosa-associated lymphoid tissue lymphoma (MALT) successfully treated by radiation therapy. Nihon Shokakibyo Gakkai Zasshi 108(7):1231–1236PubMed

30.

De Sanctis V, Marignani M, Angeletti S, Assisi D, Armosini V, Valeriani M, Minniti G, Cox MC, Ruco L, Enrici RM (2012) Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum. Tumori 98(4):105–110

31.

Mangla V, Pal S, Dash NR, Das P, Ahuja V, Sharma A, Sahni P, Chattopadhyay TK (2012) Rectal MALT lymphoma associated with ulcerative colitis. Trop Gastroenterol 33(3):225–228CrossRefPubMed

32.

Ohara E, Kitadai Y, Onoyama M, Ohnishi M, Shinagawa K, Oka S, Yoshida S, Tanaka S, Sakamoto N, Yasui W, Shimamoto F, Chayama K (2012) Regression of rectal MALT lymphoma after antibiotic treatment in a patient negative for Helicobacter pylori. Clin J Gastroenterol 5(1):59–63CrossRefPubMed

33.

Okamura T, Suga T, Iwaya Y, Ito T, Yokosawa S, Arakura N, Ota H, Tanaka E (2012) Helicobacter pylori-negative primary rectal MALT lymphoma: complete remission after radiotherapy. Case Rep Gastroenterol 6(2):319–327CrossRefPubMedPubMedCentral

34.

Park H, Chung JW, Kim AJ, Park SY, Rim MY, Jang YR, Lee JH, Park S (2012) A case of rectal mucosa-associated lymphoid tissue lymphoma diagnosed by endoscopic unroofing technique. Korean J Gastroenterol 59(6):428–432CrossRefPubMed

35.

Matsuyama T, Kaku E, Nosaka K, Iyama K, Namimoto T, Oya N 2013 Radical radiation therapy of primary rectal mucosa-associated lymphoid tissue lymphoma after bacteria elimination therapy. International Cancer Conference Journal 2(2):63–70 (http://link.springer.com/article/10.1007/s13691-013-0091-0)

36.

Omidvari S, Nasrolhai H, MoaddadShoar L, Hamedi S, Mohammadianpanah M, Daneshbod Y, Ansari M, Ahmadloo N, Mosalaei A 2013 Primary mucosa-associated lymphoid tissue lymphoma of the rectum. Ann Colorectal Res 1(3):106–10 (http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0ahUKEwjohs-Rn4XPAhUX7WMKHR46BaAQFggcMAA&url=http %3A %2F %2Fcolorectalresearch.com %2F34334.pdf&usg=AFQjCNE3izGugr8QlkM8xnqd4jtD7FDhSA&sig2=v4aY6yms0hha1NTSnxKNjQ&bvm=bv.132479545,d.cGc)

37.

Kelley SR, Merchea A, Abdelsattar ZM, Behm KT, Dozois EJ 2015 Management of primary rectal lymphoma: a single institution experience. World Journal of Colorectal Surgery 5(2):1–19 (http://services.bepress.com/wjcs/vol5/iss2/art4/)

38.

Sakuraba S, Orita H, Ito T, et al. 2016 A case of rectal mucosa-sssociated lymphoid tissue (MALT) lymphoma treated twice with antibiotic therapy for Helicobacter pylori. J Gastrointest Cancer Stromal Tumor 1(1):1–4 (http://www.omicsonline.org/open-access/a-case-of-rectal-mucosaassociated-lymphoid-tissue-malt-lymphoma-treated-twice-with-antibiotic-therapy-for-helicobacter-pylori-jgcst-1000104.pdf)

39.

Isaacson PG, Wright DH (1983) Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 52:1410–1416CrossRefPubMed

40.

Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, et al. 1994 A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 84(5):1361–92

41.

Crump M, Gospodarowicz M, Shepherd FA (1999) Lymphoma of the gastrointestinal tract. Semin Oncol 26:324–337PubMed

42.

Cardona DM, Layne A, Lagoo AS (2012) Lymphomas of the gastro-intestinal tract. Pathophysiology, pathology, and differential diagnosis. Indian J Pathol Microbiol 55(1):1CrossRefPubMed

43.

Korelitz BI, Mirsky FJ, Fleisher MR, Warman JI, Wisch N, Gleim GW (1999) Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Am J Gastroenterol 94:3248–3253CrossRefPubMed

44.

Wong MT, Eu KW (2006) Primary colorectal lymphomas. Color Dis 8:586–591CrossRef

45.

Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F 2009 CESAME Study Group. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 374:1617–25

46.

Pinotti G, Zucca E, Roggero E, Pascarella A, Bertoni F, Savio A, Savio E, Capella C, Pedrinis E, Saletti P, Morandi E, Santandrea G, Cavalli F (1997) Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymph 26(5–6):527–537CrossRef

47.

Zinzani PL, Magagnoli M, Galieni P, Martelli M, Poletti V, Zaja F, Molica S, Zaccaria A, Cantonetti AM, Gentilini P, Guardigni L, Gherlinzoni F, Ribersani M, Bendandi M, Albertini P, Tura S (1999) Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 17:1254PubMed

48.

Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, de Argila CM, Bellas C (2001) Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica 86:609–617PubMed

49.

Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG (1991) Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175–1176CrossRefPubMed

50.

Pounder RE, Ng D (1995) The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 9(2):33–40PubMed

51.

Al-Saleem T, Al-Mondhiry H (2005) Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood 105:2274–2280CrossRefPubMed

52.

Roggero E, Zucca E, Mainetti C, Bertoni F, Valsangiacomo C, Pedrinis E, Borisch B, Piffaretti JC, Cavalli F, Isaacson PG (2000) Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 31:263–268CrossRefPubMed

53.

Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell'Oro S, Fleischhauer K, Caggiari L, Lettini AA, Dal Cin E, Ieri R, Freschi M, Villa E, Boiocchi M, Dolcetti R (2004) Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 96:571–573CrossRef

54.

Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B, Wündisch T, Ehninger G, Stolte M, Bayerdörffer E (1997) Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 89:1350–1355CrossRefPubMed

55.

Dierlamm J, Baens M, Wlodarak I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, De Wolf-Peeters C, Hagemeijer A, Van den Berghe H, Marynen P (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93:3601–3609PubMed

56.

Akagi T, Motegi M, Tamura A, Suzuki R, Hosokawa Y, Suzuki H, Ota H, Nakamura S, Morishima Y, Taniwaki M, Seto M (1999) A novel gene, MALT1 at 18q21, is involved in t (11; 18)(q21; q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 18(42):5785–5794CrossRefPubMed

57.

Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, Diss TC, Dogan A, Megraud F, Rambaud JC, Du MQ, Isaacson PG (2001) Resistance of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357:39–40CrossRefPubMed

58.

Nakamura T, Nakamura S, Yokoi, Suzuki H, Ohashi K, Seto M (2002) Clinicopathologic comparison between API1-MALT1 chimeric transcript-positive and negative gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J Cancer Res 93(6):677–684CrossRefPubMed

59.

Sakugawa ST, Yoshino T, Nakamura S, Inagaki H, Sadahira Y, Nakamine H, Okabe M, Ichimura K, Tanimoto M, Akagi T (2003) API2-MALT1 fusion gene in colorectal lymphoma. Mod Pathol 16(12):1232–1241CrossRefPubMed

60.

Yanezumi M, Suzuki R, Suzuki H, Yoshino T, Oshima K, Hosokawa Y, Asaka M, Morishima Y, Nakamura S, Seto M (2001) Detection of AP12-MALT1 chimaeric gene in extranodal and nodal marginal zone B-cell lymphoma by reverse transcription polymerase chain reaction (PCR) and genomic long and accurate PCU analyses. Br J Haematol 115:588–594CrossRef

61.

Isobe K, Kagami Y, Higuchi K, Kodaira T, Hasegawa M, Shikama N, Nakazawa M, Fukuda I, Nihei K, Oguchi M, Japan Radiation Oncology Group, Ito K, Teshima T, Matsuno Y (2007) A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG). International Journal of Radiation Oncology 69(4):1181–1186CrossRef

62.

Yamashita H, Nakagawa K, Asari T, Murakami N, Igaki H, Ohtomo K (2008) Radiotherapy for 41 cases with stages I and II MALT lymphoma: a retrospective study. Radiother Oncol 87(3):412–417CrossRefPubMed

Title: Mucosa-associated lymphoid tissue (MALT) variant of primary rectal lymphoma: a review of the English literature
Author: Scott R. Kelley
Publication date: 01-03-2017
Publisher: Springer Berlin Heidelberg
Published in: International Journal of Colorectal Disease / Issue 3/2017
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-016-2734-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Mucosa-associated lymphoid tissue (MALT) variant of primary rectal lymphoma: a review of the English literature

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2017

Predictors of outcome for endoscopic colorectal stenting: a decade experience

Downregulation of CX3CR1 ameliorates experimental colitis: evidence for CX3CL1-CX3CR1-mediated immune cell recruitment

Postoperative recurrence and risk factors of colorectal cancer perforation

Does the depth of mesorectal invasion have prognostic significance in patients with ypT3 lower rectal cancer treated with preoperative chemoradiotherapy?

A single institution’s long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy

A randomized controlled trial of subcutaneous closed-suction Blake drains for the prevention of incisional surgical site infection after colorectal surgery